By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

aTyr Pharma Inc. 

10685 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-731-8389 Fax: 858-731-8394


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
aTyr Pharma Announces Fourth Quarter And Year-End 2016 Operating Results 3/17/2017 11:11:07 AM
aTyr Pharma Announces Issuance Of U.S. Patent That Extends Patent Protection Of Physiocrines Derived From 20 Out Of 20 Human tRNA Synthetases 3/15/2017 6:30:08 AM
aTyr Pharma Receives EMA Orphan Drug Designation For The Treatment Of Limb Girdle Muscular Dystrophy With Resolaris 3/3/2017 6:33:59 AM
aTyr Pharma Receives U.S. FDA Orphan Drug Designation For The Treatment Of Limb Girdle Muscular Dystrophy With Resolaris 2/28/2017 6:19:06 AM
aTyr Pharma Release: FDA Grants Fast Track Designation For Company's Resolaris To Treat Limb Girdle Muscular Dystrophy 2B And Removes Partial Clinical Hold For Resolaris 1/18/2017 8:08:39 AM
aTyr Pharma Reports Promising Signals Of Clinical Activity In Multiple Rare Genetically Distinct Myopathies With Resolaris In Exploratory Trials 12/13/2016 6:41:40 AM
aTyr Pharma Enters Into $20 Million Credit Facility 11/21/2016 10:17:31 AM
aTyr Pharma Announces Third Quarter 2016 Operating Results 11/14/2016 11:29:44 AM
aTyr Pharma Receives FDA Fast Track Designation For Resolaris To Treat Facioscapulohumeral Muscular Dystrophy (FSHD) 10/24/2016 7:22:39 AM
aTyr Pharma Presents Additional Data For Resolaris Phase 1b/2 Trial In Adult Patients With Facioscapulohumeral Muscular Dystrophy At The 21st International Annual Congress Of The World Muscle Society 10/6/2016 7:41:51 AM
12345678
//-->